These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31342441)

  • 41. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.
    Ciccone G; Ibba ML; Coppola G; Catuogno S; Esposito CL
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies.
    Adachi H; Hengesbach M; Yu YT; Morais P
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translational development of splice-modifying antisense oligomers.
    Fletcher S; Bellgard MI; Price L; Akkari AP; Wilton SD
    Expert Opin Biol Ther; 2017 Jan; 17(1):15-30. PubMed ID: 27805416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
    Phillips MI
    Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy.
    Scalet D; Balestra D; Rohban S; Bovolenta M; Perrone D; Bernardi F; Campaner S; Pinotti M
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):15-20. PubMed ID: 27639833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleic acid therapeutics in neurodevelopmental disease.
    Winkelsas AM; Fischbeck KH
    Curr Opin Genet Dev; 2020 Dec; 65():112-116. PubMed ID: 32623324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies.
    Garanto A
    Adv Exp Med Biol; 2019; 1185():71-77. PubMed ID: 31884591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antisense oligonucleotides: the state of the art.
    Aboul-Fadl T
    Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides.
    Bertoni C
    Front Biosci; 2008 Jan; 13():517-27. PubMed ID: 17981565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
    Bejar N; Tat TT; Kiss DL
    Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of pre-mRNA splicing by antisense oligonucleotides.
    Kole R
    Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antisense therapy for angioplasty restenosis. Some critical considerations.
    Bennett MR; Schwartz SM
    Circulation; 1995 Oct; 92(7):1981-93. PubMed ID: 7671381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oligonucleotide therapeutics in cancer.
    Wan J; Bauman JA; Graziewicz MA; Sazani P; Kole R
    Cancer Treat Res; 2013; 158():213-33. PubMed ID: 24222360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA therapeutics: updates and future potential.
    Zhang C; Zhang B
    Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.
    Gerard X; Garanto A; Rozet JM; Collin RW
    Adv Exp Med Biol; 2016; 854():517-24. PubMed ID: 26427454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA base editors: The emerging approach of RNA therapeutics.
    Song J; Luo N; Dong L; Peng J; Yi C
    Wiley Interdiscip Rev RNA; 2024; 15(2):e1844. PubMed ID: 38576085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent applications of RNA therapeutic in clinics.
    Ha Thi HT; Than VT
    Prog Mol Biol Transl Sci; 2024; 203():115-150. PubMed ID: 38359994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the lung using siRNA and antisense based oligonucleotides.
    Moschos SA; Spinks K; Williams AE; Lindsay MA
    Curr Pharm Des; 2008; 14(34):3620-7. PubMed ID: 19075738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The current landscape of nucleic acid therapeutics.
    Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R
    Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress in Respiratory Gene Therapy.
    McLachlan G; Alton EWFW; Boyd AC; Clarke NK; Davies JC; Gill DR; Griesenbach U; Hickmott JW; Hyde SC; Miah KM; Molina CJ
    Hum Gene Ther; 2022 Sep; 33(17-18):893-912. PubMed ID: 36074947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.